TERM ID="NYU_TERM_1" STRING="Recent developments" FREQUENCY=1 START=154 END=173 LEMMA="RECENT DEVELOPMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="antiangiogenic agents" FREQUENCY=1 START=321 END=342 LEMMA="ANTIANGIOGENIC AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="biomarkers" FREQUENCY=1 START=576 END=586 LEMMA="BIOMARKER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="cancer biology" FREQUENCY=1 START=198 END=212 LEMMA="CANCER BIOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="clinical trials" FREQUENCY=1 START=241 END=256 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="diagnostic techniques" FREQUENCY=1 START=55 END=76 LEMMA="DIAGNOSTIC TECHNIQUE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="epithelial ovarian cancer" FREQUENCY=2 START=114 END=139 LEMMA="EPITHELIAL OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_8" STRING="epithelial ovarian cancer" FREQUENCY=2 START=294 END=319 LEMMA="EPITHELIAL OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_9" STRING="improvements" FREQUENCY=1 START=26 END=38 LEMMA="IMPROVEMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="incorporation" FREQUENCY=1 START=559 END=572 LEMMA="INCORPORATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="incorporation of biomarkers" FREQUENCY=1 START=559 END=586 LEMMA="BIOMARKER INCORPORATION" LEMMA_FREQUENCY=1 HEAD_TERM="incorporation" HEAD_LEMMA="INCORPORATION"
TERM ID="NYU_TERM_12" STRING="targeted agents" FREQUENCY=1 START=263 END=278 LEMMA="TARGETED AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="undergoing evaluation" FREQUENCY=1 START=414 END=435 LEMMA="UNDERGOING EVALUATION" LEMMA_FREQUENCY=1
